Full text is available at the source.
Non-canonical CRISPR/Cas12a-based technology: A novel horizon for biosensing in nucleic acid detection
New CRISPR/Cas12a method for detecting genetic material in biosensors
AI simplified
Abstract
Non-canonical CRISPR/Cas12a-based biosensors may improve nucleic acid detection capabilities.
- Canonical CRISPR/Cas12a biosensors are known for their high specificity and simple operation but struggle with sensitivity and efficiency.
- Non-canonical CRISPR/Cas12a biosensors could address limitations related to target scope, multiplexing, and signal detection.
- This review summarizes the applications, principles, and characteristics of non-canonical CRISPR/Cas12a-based biosensors.
- Performance metrics and future prospects of these advanced biosensors are discussed.
AI simplified